ClonBio Group Limited is a family-owned Irish agribusiness specializing in the production of sustainable bioproducts from grain. Serving as a market leader and large-scale producer of renewable energy and animal nutrition in Europe, the company continues to invest in biotechnology to develop commercially viable bioproducts. Over the past decade, the Group has made significant strides, investing €250 million to establish Europe’s largest grain-based biorefinery. Operating through its subsidiary, Pannonia Bio Zrt. (www.pannoniabio.com), the company strategically situates its facility close to its corn feedstock source in the fertile crop-growing regions of Hungary. The refining process focuses on extracting constituent elements of feed corn, such as starch, protein, fiber, and oils, to create raw materials for renewable bioproducts. At present, the biorefinery is engaged in the production of ethanol and protein-enriched animal feed on a large scale, while also serving as an incubator for bioproducts by trialing and scaling laboratory-proven concepts. Moreover, the Group collaborates with concept originators to develop novel bioproducts in nutrition, health, biochemical, and energy markets. Since its establishment in 2010, ClonBio Group Limited has carved its niche in the Energy, Manufacturing, and Renewable Energy industries, poised for further growth and innovation.
There is no investment information
No recent news or press coverage available for ClonBio Group Limited.